IL144603A0 - Controlled release formulation for treating copd - Google Patents

Controlled release formulation for treating copd

Info

Publication number
IL144603A0
IL144603A0 IL14460300A IL14460300A IL144603A0 IL 144603 A0 IL144603 A0 IL 144603A0 IL 14460300 A IL14460300 A IL 14460300A IL 14460300 A IL14460300 A IL 14460300A IL 144603 A0 IL144603 A0 IL 144603A0
Authority
IL
Israel
Prior art keywords
controlled release
release formulation
treating copd
copd
treating
Prior art date
Application number
IL14460300A
Other languages
English (en)
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of IL144603A0 publication Critical patent/IL144603A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A61K31/277—Nitriles; Isonitriles having a ring, e.g. verapamil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Inorganic Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL14460300A 1999-02-23 2000-02-22 Controlled release formulation for treating copd IL144603A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12129199P 1999-02-23 1999-02-23
PCT/US2000/004713 WO2000050011A1 (en) 1999-02-23 2000-02-22 Controlled release formulation for treating copd

Publications (1)

Publication Number Publication Date
IL144603A0 true IL144603A0 (en) 2002-05-23

Family

ID=22395738

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14460300A IL144603A0 (en) 1999-02-23 2000-02-22 Controlled release formulation for treating copd

Country Status (29)

Country Link
US (1) US20030211152A1 (sk)
EP (1) EP1154758A4 (sk)
JP (1) JP2002537320A (sk)
KR (1) KR20010112279A (sk)
CN (1) CN1195496C (sk)
AR (1) AR028986A1 (sk)
AU (1) AU3501500A (sk)
BG (1) BG105905A (sk)
BR (1) BR0008382A (sk)
CA (1) CA2366747A1 (sk)
CO (1) CO5150233A1 (sk)
CZ (1) CZ20013025A3 (sk)
EA (1) EA200100906A1 (sk)
HK (1) HK1043045A1 (sk)
HU (1) HUP0200134A3 (sk)
ID (1) ID29792A (sk)
IL (1) IL144603A0 (sk)
MA (1) MA25386A1 (sk)
MY (1) MY121142A (sk)
NO (1) NO20014049L (sk)
NZ (1) NZ527716A (sk)
OA (1) OA11836A (sk)
PE (1) PE20001496A1 (sk)
PL (1) PL350287A1 (sk)
SK (1) SK12072001A3 (sk)
TR (1) TR200102448T2 (sk)
TW (1) TWI224013B (sk)
WO (1) WO2000050011A1 (sk)
ZA (1) ZA200106803B (sk)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU772909B2 (en) * 1999-10-29 2004-05-13 Smithkline Beecham Corporation Method for administering a phosphodiesterase 4 inhibitor
CA2447618A1 (en) * 2001-05-23 2002-11-28 Tanabe Seiyaku Co., Ltd. A composition for regenerative treatment of cartilage disease
MXPA03010679A (es) * 2001-05-23 2004-03-02 Tanabe Seiyaku Co Una composicion para acelerar la cicatrizacion de fractura osea.
MXPA04002560A (es) * 2001-09-19 2004-05-31 Altana Pharma Ag Combinacion de un nsaid y un inhibidor pde-4.
MY140561A (en) * 2002-02-20 2009-12-31 Nycomed Gmbh Dosage form containing pde 4 inhibitor as active ingredient
TWI328009B (en) 2003-05-21 2010-08-01 Glaxo Group Ltd Quinoline derivatives as phosphodiesterase inhibitors
EP1667661A1 (en) * 2003-09-30 2006-06-14 Lupin Limited Extended release formulation of beta-lactam antibiotics
AR049384A1 (es) 2004-05-24 2006-07-26 Glaxo Group Ltd Derivados de purina
CN101005830B (zh) * 2004-08-13 2010-09-29 贝林格尔·英格海姆国际有限公司 包含普拉克索或其可药用盐的延长释放片剂、其制备方法及用途
GB0511066D0 (en) * 2005-05-31 2005-07-06 Novartis Ag Organic compounds
GB0514809D0 (en) 2005-07-19 2005-08-24 Glaxo Group Ltd Compounds
CN109908139B (zh) * 2018-12-28 2022-02-22 南京市儿童医院 西洛司特在制备用于治疗急性肾损伤相关病症的药物中的用途
EP4282414A3 (en) * 2019-01-15 2024-02-21 UNION therapeutics A/S Modified release tablet formulations containing phosphodiesterase inhibitors

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL297088A (sk) * 1961-01-31
IL78017A (en) * 1986-03-03 1989-06-30 Yissum Res Dev Co Sustained release tablets of theophylline
US5286494A (en) * 1986-07-02 1994-02-15 Schering Aktiengesellschaft Medicinal agents with sustained action
EP0633776B1 (en) * 1992-04-02 2001-05-09 Smithkline Beecham Corporation Compounds useful for treating allergic and inflammatory diseases
GB9222253D0 (en) * 1992-10-23 1992-12-09 Celltech Ltd Chemical compounds
US5672622A (en) * 1994-04-21 1997-09-30 Berlex Laboratories, Inc. Treatment of multiple sclerosis
US5998428A (en) * 1995-05-31 1999-12-07 Smithkline Beecham Corporation Compounds and methods for treating PDE IV-related diseases
US6210710B1 (en) * 1997-04-28 2001-04-03 Hercules Incorporated Sustained release polymer blend for pharmaceutical applications
US5840329A (en) * 1997-05-15 1998-11-24 Bioadvances Llc Pulsatile drug delivery system
AR035987A1 (es) * 1999-03-01 2004-08-04 Smithkline Beecham Corp Uso de un compuesto inhibidor de la pde 4 para la manufactura de un medicamento y el medicamento para tratar asma inducida por ejercicio

Also Published As

Publication number Publication date
US20030211152A1 (en) 2003-11-13
TR200102448T2 (tr) 2003-03-21
JP2002537320A (ja) 2002-11-05
TWI224013B (en) 2004-11-21
AU3501500A (en) 2000-09-14
ZA200106803B (en) 2002-08-19
BG105905A (bg) 2002-04-30
EP1154758A1 (en) 2001-11-21
EP1154758A4 (en) 2007-09-05
HUP0200134A3 (en) 2003-03-28
WO2000050011A1 (en) 2000-08-31
EA200100906A1 (ru) 2002-02-28
ID29792A (id) 2001-10-11
BR0008382A (pt) 2002-02-05
PE20001496A1 (es) 2001-02-08
CO5150233A1 (es) 2002-04-29
OA11836A (en) 2005-08-22
MY121142A (en) 2005-12-30
CN1347314A (zh) 2002-05-01
CZ20013025A3 (cs) 2002-07-17
KR20010112279A (ko) 2001-12-20
CA2366747A1 (en) 2000-08-31
NZ527716A (en) 2005-03-24
HK1043045A1 (zh) 2002-09-06
NO20014049L (no) 2001-10-22
PL350287A1 (en) 2002-12-02
CN1195496C (zh) 2005-04-06
AR028986A1 (es) 2003-06-04
NO20014049D0 (no) 2001-08-20
HUP0200134A2 (hu) 2002-05-29
SK12072001A3 (sk) 2002-01-07
MA25386A1 (fr) 2002-04-01

Similar Documents

Publication Publication Date Title
HUP0203680A3 (en) Controlled release hydrocodone formulations
GB9826662D0 (en) Controlled release formulation
HUP0301591A3 (en) Controlled release hydrocodone compositions
EP1189655A4 (en) DEVICE FOR IMPLANTING
GB0118884D0 (en) Apparatus for treating objects
IL144428A0 (en) Method for improved radiation theraphy
GB9925360D0 (en) Control apparatus
GB9900150D0 (en) Treatment for fabrics
IL144603A0 (en) Controlled release formulation for treating copd
EP1225971A4 (en) CONTROLLED RELEASE OF SUBSTANCES
GB0118349D0 (en) Apparatus for treating objects
GB0118881D0 (en) Apparatus for treating objects
IL144992A0 (en) Method for treating copd
EG22865A (en) Treatment compositions for fabrics
GB0121048D0 (en) Apparatus for treating objects
HUP0200842A3 (en) Combination preparation for treating malaria
GB9900151D0 (en) Treatment for fabrics
GB9930591D0 (en) Component for vaccine
AU2002365136A8 (en) Compositions and methods for controlled release
GB2349933B (en) Apparatus for treating elongate members
HU0001889D0 (en) Pharmaceutical composition for treating migraine
HU9902296D0 (en) Pharmaceutical composition for treating caltification
GB9930585D0 (en) Component for vaccine
GB9914283D0 (en) Method for controlling the release of vapours
GB9909623D0 (en) Apparatus for spreading